Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 225

1.

Synthesis and Anticancer Activity of Gold Porphyrin Linked to Malonate Diamine Platinum Complexes.

Toubia I, Nguyen C, Diring S, Ali LMA, Larue L, Aoun R, Frochot C, Gary-Bobo M, Kobeissi M, Odobel F.

Inorg Chem. 2019 Sep 16;58(18):12395-12406. doi: 10.1021/acs.inorgchem.9b01981. Epub 2019 Sep 5.

PMID:
31522505
2.

Modeling and analysis of melanoblast motion.

Laurent-Gengoux P, Petit V, Larue L.

J Math Biol. 2019 Sep 12. doi: 10.1007/s00285-019-01422-8. [Epub ahead of print]

PMID:
31515603
3.

LKB1 specifies neural crest cell fates through pyruvate-alanine cycling.

Radu AG, Torch S, Fauvelle F, Pernet-Gallay K, Lucas A, Blervaque R, Delmas V, Schlattner U, Lafanechère L, Hainaut P, Tricaud N, Pingault V, Bondurand N, Bardeesy N, Larue L, Thibert C, Billaud M.

Sci Adv. 2019 Jul 17;5(7):eaau5106. doi: 10.1126/sciadv.aau5106. eCollection 2019 Jul.

4.

C57BL/6 congenic mouse NRASQ61K melanoma cell lines are highly sensitive to the combination of Mek and Akt inhibitors in vitro and in vivo.

Petit V, Raymond J, Alberti C, Pouteaux M, Gallagher SJ, Nguyen MQ, Aplin AE, Delmas V, Larue L.

Pigment Cell Melanoma Res. 2019 Nov;32(6):829-841. doi: 10.1111/pcmr.12807. Epub 2019 Jul 15.

PMID:
31251472
5.

Chromatin remodellers Brg1 and Bptf are required for normal gene expression and progression of oncogenic Braf-driven mouse melanoma.

Laurette P, Coassolo S, Davidson G, Michel I, Gambi G, Yao W, Sohier P, Li M, Mengus G, Larue L, Davidson I.

Cell Death Differ. 2019 May 7. doi: 10.1038/s41418-019-0333-6. [Epub ahead of print]

PMID:
31065107
6.

Rate of Fentanyl Positivity Among Urine Drug Test Results Positive for Cocaine or Methamphetamine.

LaRue L, Twillman RK, Dawson E, Whitley P, Frasco MA, Huskey A, Guevara MG.

JAMA Netw Open. 2019 Apr 5;2(4):e192851. doi: 10.1001/jamanetworkopen.2019.2851.

7.

BRN2 suppresses apoptosis, reprograms DNA damage repair, and is associated with a high somatic mutation burden in melanoma.

Herbert K, Binet R, Lambert JP, Louphrasitthiphol P, Kalkavan H, Sesma-Sanz L, Robles-Espinoza CD, Sarkar S, Suer E, Andrews S, Chauhan J, Roberts ND, Middleton MR, Gingras AC, Masson JY, Larue L, Falletta P, Goding CR.

Genes Dev. 2019 Mar 1;33(5-6):310-332. doi: 10.1101/gad.314633.118. Epub 2019 Feb 25.

8.

MITF has a central role in regulating starvation-induced autophagy in melanoma.

Möller K, Sigurbjornsdottir S, Arnthorsson AO, Pogenberg V, Dilshat R, Fock V, Brynjolfsdottir SH, Bindesboll C, Bessadottir M, Ogmundsdottir HM, Simonsen A, Larue L, Wilmanns M, Thorsson V, Steingrimsson E, Ogmundsdottir MH.

Sci Rep. 2019 Jan 31;9(1):1055. doi: 10.1038/s41598-018-37522-6.

9.

Tspan8-β-catenin positive feedback loop promotes melanoma invasion.

El Kharbili M, Agaësse G, Barbollat-Boutrand L, Pommier RM, de la Fouchardière A, Larue L, Caramel J, Puisieux A, Berthier-Vergnes O, Masse I.

Oncogene. 2019 May;38(20):3781-3793. doi: 10.1038/s41388-019-0691-z. Epub 2019 Jan 24.

PMID:
30679790
10.

Thymine DNA glycosylase as a novel target for melanoma.

Mancuso P, Tricarico R, Bhattacharjee V, Cosentino L, Kadariya Y, Jelinek J, Nicolas E, Einarson M, Beeharry N, Devarajan K, Katz RA, Dorjsuren DG, Sun H, Simeonov A, Giordano A, Testa JR, Davidson G, Davidson I, Larue L, Sobol RW, Yen TJ, Bellacosa A.

Oncogene. 2019 May;38(19):3710-3728. doi: 10.1038/s41388-018-0640-2. Epub 2019 Jan 23.

11.

TET2-Dependent Hydroxymethylome Plasticity Reduces Melanoma Initiation and Progression.

Bonvin E, Radaelli E, Bizet M, Luciani F, Calonne E, Putmans P, Nittner D, Singh NK, Santagostino SF, Petit V, Larue L, Marine JC, Fuks F.

Cancer Res. 2019 Feb 1;79(3):482-494. doi: 10.1158/0008-5472.CAN-18-1214. Epub 2018 Dec 11.

PMID:
30538121
12.

Molecular and cellular basis of depigmentation in vitiligo patients.

Delmas V, Larue L.

Exp Dermatol. 2019 Jun;28(6):662-666. doi: 10.1111/exd.13858. Epub 2019 Jan 15. Review.

PMID:
30536790
13.

The triennial International Pigment Cell Conference (IPCC).

Box NF, Larue L, Manga P, Montoliu L, Spritz RA, Filipp FV.

J Transl Med. 2018 Oct 3;16(1):252. doi: 10.1186/s12967-018-1609-1.

14.

Frontiers in pigment cell and melanoma research.

Filipp FV, Birlea S, Bosenberg MW, Brash D, Cassidy PB, Chen S, D'Orazio JA, Fujita M, Goh BK, Herlyn M, Indra AK, Larue L, Leachman SA, Le Poole C, Liu-Smith F, Manga P, Montoliu L, Norris DA, Shellman Y, Smalley KSM, Spritz RA, Sturm RA, Swetter SM, Terzian T, Wakamatsu K, Weber JS, Box NF.

Pigment Cell Melanoma Res. 2018 Nov;31(6):728-735. doi: 10.1111/pcmr.12728. Epub 2018 Oct 3.

15.

Use of Cyclodextrins in Anticancer Photodynamic Therapy Treatment.

Ben Mihoub A, Larue L, Moussaron A, Youssef Z, Colombeau L, Baros F, Frochot C, Vanderesse R, Acherar S.

Molecules. 2018 Aug 2;23(8). pii: E1936. doi: 10.3390/molecules23081936. Review.

16.

Using X-rays in photodynamic therapy: an overview.

Larue L, Ben Mihoub A, Youssef Z, Colombeau L, Acherar S, André JC, Arnoux P, Baros F, Vermandel M, Frochot C.

Photochem Photobiol Sci. 2018 Nov 1;17(11):1612-1650. doi: 10.1039/c8pp00112j. Epub 2018 Jun 25. Review.

PMID:
29938265
17.

[Cutaneous melanoma: from rationalized models to patients care].

Gesbert F, Larue L.

Med Sci (Paris). 2018 May;34(5):407-416. doi: 10.1051/medsci/20183405013. Epub 2018 Jun 13. Review. French.

18.

Simulation of melanoblast displacements reveals new features of developmental migration.

Laurent-Gengoux P, Petit V, Aktary Z, Gallagher S, Tweedy L, Machesky L, Larue L.

Development. 2018 Jun 11;145(12). pii: dev160200. doi: 10.1242/dev.160200.

19.

Filamentous Aggregation of Sequestosome-1/p62 in Brain Neurons and Neuroepithelial Cells upon Tyr-Cre-Mediated Deletion of the Autophagy Gene Atg7.

Sukseree S, László L, Gruber F, Bergmann S, Narzt MS, Nagelreiter IM, Höftberger R, Molnár K, Rauter G, Birngruber T, Larue L, Kovacs GG, Tschachler E, Eckhart L.

Mol Neurobiol. 2018 Nov;55(11):8425-8437. doi: 10.1007/s12035-018-0996-x. Epub 2018 Mar 17.

20.

Epidermal melanocytes in segmental vitiligo show altered expression of E-cadherin, but not P-cadherin.

Grill C, Benzekri L, Rubod A, Aktary Z, Ezzedine K, Taïeb A, Gauthier Y, Larue L, Delmas V.

Br J Dermatol. 2018 May;178(5):1204-1206. doi: 10.1111/bjd.16352. Epub 2018 Mar 25. No abstract available.

PMID:
29341072
21.

A histopathological classification system of Tyr::NRASQ61K murine melanocytic lesions: A reproducible simplified classification.

Sohier P, Legrand L, Aktary Z, Grill C, Delmas V, Bernex F, Reyes-Gomez E, Larue L, Vergier B.

Pigment Cell Melanoma Res. 2018 May;31(3):423-431. doi: 10.1111/pcmr.12677. Epub 2017 Dec 22.

PMID:
29224244
22.

The patterns of birthmarks suggest a novel population of melanocyte precursors arising around the time of gastrulation.

Kinsler VA, Larue L.

Pigment Cell Melanoma Res. 2018 Jan;31(1):95-109. doi: 10.1111/pcmr.12645. Epub 2017 Oct 13.

23.

The immune system prevents recurrence of transplanted but not autochthonous antigenic tumors after oncogene inactivation therapy.

Anders K, Kershaw O, Larue L, Gruber AD, Blankenstein T.

Int J Cancer. 2017 Dec 15;141(12):2551-2561. doi: 10.1002/ijc.31009. Epub 2017 Aug 31.

24.

The tumour suppressor, miR-137, inhibits malignant melanoma migration by targetting the TBX3 transcription factor.

Peres J, Kwesi-Maliepaard EM, Rambow F, Larue L, Prince S.

Cancer Lett. 2017 Oct 1;405:111-119. doi: 10.1016/j.canlet.2017.07.018. Epub 2017 Jul 28.

PMID:
28757416
25.

Routing of the RAB6 secretory pathway towards the lysosome related organelle of melanocytes.

Patwardhan A, Bardin S, Miserey-Lenkei S, Larue L, Goud B, Raposo G, Delevoye C.

Nat Commun. 2017 Jun 13;8:15835. doi: 10.1038/ncomms15835.

26.

RAF proteins exert both specific and compensatory functions during tumour progression of NRAS-driven melanoma.

Dorard C, Estrada C, Barbotin C, Larcher M, Garancher A, Leloup J, Beermann F, Baccarini M, Pouponnot C, Larue L, Eychène A, Druillennec S.

Nat Commun. 2017 May 12;8:15262. doi: 10.1038/ncomms15262.

27.

Transvaginal ultrasound-guided embryo transfer in IVF.

Larue L, Keromnes G, Massari A, Roche C, Moulin J, Gronier H, Bouret D, Cassuto NG, Ayel JP.

J Gynecol Obstet Hum Reprod. 2017 May;46(5):411-416. doi: 10.1016/j.jogoh.2017.02.015. Epub 2017 Apr 17.

PMID:
28428123
28.

Anatomical causes of difficult embryo transfer during in vitro fertilization.

Larue L, Keromnes G, Massari A, Roche C, Bouret D, Cassuto NG, Ayel JP.

J Gynecol Obstet Hum Reprod. 2017 Jan;46(1):77-86. doi: 10.1016/j.jgyn.2016.09.004. Epub 2016 Oct 17.

PMID:
28403960
29.

Structure-based mutational analysis of ICAT residues mediating negative regulation of β-catenin co-transcriptional activity.

Domingues MJ, Martinez-Sanz J, Papon L, Larue L, Mouawad L, Bonaventure J.

PLoS One. 2017 Mar 8;12(3):e0172603. doi: 10.1371/journal.pone.0172603. eCollection 2017.

30.

Coordination by Cdc42 of Actin, Contractility, and Adhesion for Melanoblast Movement in Mouse Skin.

Woodham EF, Paul NR, Tyrrell B, Spence HJ, Swaminathan K, Scribner MR, Giampazolias E, Hedley A, Clark W, Kage F, Marston DJ, Hahn KM, Tait SW, Larue L, Brakebusch CH, Insall RH, Machesky LM.

Curr Biol. 2017 Mar 6;27(5):624-637. doi: 10.1016/j.cub.2017.01.033. Epub 2017 Feb 23.

31.

UVB represses melanocyte cell migration and acts through β-catenin.

Bertrand JU, Petit V, Hacker E, Berlin I, Hayward NK, Pouteaux M, Sage E, Whiteman DC, Larue L.

Exp Dermatol. 2017 Oct;26(10):875-882. doi: 10.1111/exd.13318. Epub 2017 May 3.

PMID:
28191677
32.

Autophagy deficient melanocytes display a senescence associated secretory phenotype that includes oxidized lipid mediators.

Ni C, Narzt MS, Nagelreiter IM, Zhang CF, Larue L, Rossiter H, Grillari J, Tschachler E, Gruber F.

Int J Biochem Cell Biol. 2016 Dec;81(Pt B):375-382. doi: 10.1016/j.biocel.2016.10.006. Epub 2016 Oct 11.

PMID:
27732890
33.

NRAS, NRAS, Which Mutation Is Fairest of Them All?

Grill C, Larue L.

J Invest Dermatol. 2016 Oct;136(10):1936-1938. doi: 10.1016/j.jid.2016.06.011.

34.

Tyrosinase-Cre-Mediated Deletion of the Autophagy Gene Atg7 Leads to Accumulation of the RPE65 Variant M450 in the Retinal Pigment Epithelium of C57BL/6 Mice.

Sukseree S, Chen YT, Laggner M, Gruber F, Petit V, Nagelreiter IM, Mlitz V, Rossiter H, Pollreisz A, Schmidt-Erfurth U, Larue L, Tschachler E, Eckhart L.

PLoS One. 2016 Aug 18;11(8):e0161640. doi: 10.1371/journal.pone.0161640. eCollection 2016.

35.

The WNT-less wonder: WNT-independent β-catenin signaling.

Aktary Z, Bertrand JU, Larue L.

Pigment Cell Melanoma Res. 2016 Sep;29(5):524-40. doi: 10.1111/pcmr.12501. Epub 2016 Aug 1. Review.

PMID:
27311806
36.

Any route for melanoblasts to colonize the skin!

Petit V, Larue L.

Exp Dermatol. 2016 Sep;25(9):669-73. doi: 10.1111/exd.13061. Epub 2016 Jul 13. Review.

PMID:
27119971
37.

Regulation of Melanoma Progression through the TCF4/miR-125b/NEDD9 Cascade.

Rambow F, Bechadergue A, Luciani F, Gros G, Domingues M, Bonaventure J, Meurice G, Marine JC, Larue L.

J Invest Dermatol. 2016 Jun;136(6):1229-1237. doi: 10.1016/j.jid.2016.02.803. Epub 2016 Mar 9.

38.

Meningeal Melanocytes in the Mouse: Distribution and Dependence on Mitf.

Gudjohnsen SA, Atacho DA, Gesbert F, Raposo G, Hurbain I, Larue L, Steingrimsson E, Petersen PH.

Front Neuroanat. 2015 Nov 25;9:149. doi: 10.3389/fnana.2015.00149. eCollection 2015.

39.

New Functional Signatures for Understanding Melanoma Biology from Tumor Cell Lineage-Specific Analysis.

Rambow F, Job B, Petit V, Gesbert F, Delmas V, Seberg H, Meurice G, Van Otterloo E, Dessen P, Robert C, Gautheret D, Cornell RA, Sarasin A, Larue L.

Cell Rep. 2015 Oct 27;13(4):840-853. doi: 10.1016/j.celrep.2015.09.037. Epub 2015 Oct 17.

40.

Deciphering the molecular basis of invasiveness in Sdhb-deficient cells.

Loriot C, Domingues M, Berger A, Menara M, Ruel M, Morin A, Castro-Vega LJ, Letouzé É, Martinelli C, Bemelmans AP, Larue L, Gimenez-Roqueplo AP, Favier J.

Oncotarget. 2015 Oct 20;6(32):32955-65. doi: 10.18632/oncotarget.5106.

41.

Chromatin-Remodelling Complex NURF Is Essential for Differentiation of Adult Melanocyte Stem Cells.

Koludrovic D, Laurette P, Strub T, Keime C, Le Coz M, Coassolo S, Mengus G, Larue L, Davidson I.

PLoS Genet. 2015 Oct 6;11(10):e1005555. doi: 10.1371/journal.pgen.1005555. eCollection 2015 Oct.

42.

What's up NF1?

Grill C, Larue L.

Pigment Cell Melanoma Res. 2016 Jan;29(1):4-5. doi: 10.1111/pcmr.12423. Epub 2015 Nov 3. No abstract available.

PMID:
26394792
43.

A caveolin-dependent and PI3K/AKT-independent role of PTEN in β-catenin transcriptional activity.

Conde-Perez A, Gros G, Longvert C, Pedersen M, Petit V, Aktary Z, Viros A, Gesbert F, Delmas V, Rambow F, Bastian BC, Campbell AD, Colombo S, Puig I, Bellacosa A, Sansom O, Marais R, Van Kempen LC, Larue L.

Nat Commun. 2015 Aug 26;6:8093. doi: 10.1038/ncomms9093.

44.

What is a vertebrate pigment cell?

Schartl M, Larue L, Goda M, Bosenberg MW, Hashimoto H, Kelsh RN.

Pigment Cell Melanoma Res. 2016 Jan;29(1):8-14. doi: 10.1111/pcmr.12409. Epub 2015 Nov 3. Review.

PMID:
26247887
45.

E-cadherin can limit the transforming properties of activating β-catenin mutations.

Huels DJ, Ridgway RA, Radulescu S, Leushacke M, Campbell AD, Biswas S, Leedham S, Serra S, Chetty R, Moreaux G, Parry L, Matthews J, Song F, Hedley A, Kalna G, Ceteci F, Reed KR, Meniel VS, Maguire A, Doyle B, Söderberg O, Barker N, Watson A, Larue L, Clarke AR, Sansom OJ.

EMBO J. 2015 Sep 14;34(18):2321-33. doi: 10.15252/embj.201591739. Epub 2015 Aug 3.

46.

Mitf is a master regulator of the v-ATPase, forming a control module for cellular homeostasis with v-ATPase and TORC1.

Zhang T, Zhou Q, Ogmundsdottir MH, Möller K, Siddaway R, Larue L, Hsing M, Kong SW, Goding CR, Palsson A, Steingrimsson E, Pignoni F.

J Cell Sci. 2015 Aug 1;128(15):2938-50. doi: 10.1242/jcs.173807. Epub 2015 Jun 19.

47.

Proteome characterization of melanoma exosomes reveals a specific signature for metastatic cell lines.

Lazar I, Clement E, Ducoux-Petit M, Denat L, Soldan V, Dauvillier S, Balor S, Burlet-Schiltz O, Larue L, Muller C, Nieto L.

Pigment Cell Melanoma Res. 2015 Jul;28(4):464-75. doi: 10.1111/pcmr.12380. Epub 2015 May 30.

PMID:
25950383
48.

The tyrosine phosphatase SHP2 associates with CUB domain-containing protein-1 (CDCP1), regulating its expression at the cell surface in a phosphorylation-dependent manner.

Gandji LY, Proust R, Larue L, Gesbert F.

PLoS One. 2015 Apr 13;10(4):e0123472. doi: 10.1371/journal.pone.0123472. eCollection 2015.

49.

Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo.

Wagner RY, Luciani F, Cario-André M, Rubod A, Petit V, Benzekri L, Ezzedine K, Lepreux S, Steingrimsson E, Taieb A, Gauthier Y, Larue L, Delmas V.

J Invest Dermatol. 2015 Jul;135(7):1810-1819. doi: 10.1038/jid.2015.25. Epub 2015 Jan 29.

50.

SQSTM1/p62 regulates the expression of junctional proteins through epithelial-mesenchymal transition factors.

Bertrand M, Petit V, Jain A, Amsellem R, Johansen T, Larue L, Codogno P, Beau I.

Cell Cycle. 2015;14(3):364-74. doi: 10.4161/15384101.2014.987619.

Supplemental Content

Support Center